A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy
Clinical trial NCT00639691 · COMPLETED
Trial details
- NCT number
- NCT00639691
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.